ImmunoCellular Therapeutics Alpha and Beta Analysis
| IMUCDelisted Stock | USD 0.47 0.00 0.00% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as ImmunoCellular Therapeutics. It also helps investors analyze the systematic and unsystematic risks associated with investing in ImmunoCellular Therapeutics over a specified time horizon. Remember, high ImmunoCellular Therapeutics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to ImmunoCellular Therapeutics' market risk premium analysis include:
Beta (0.80) | Alpha (0.34) | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
ImmunoCellular |
ImmunoCellular Therapeutics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. ImmunoCellular Therapeutics market risk premium is the additional return an investor will receive from holding ImmunoCellular Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in ImmunoCellular Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate ImmunoCellular Therapeutics' performance over market.| α | -0.34 | β | -0.8 |
ImmunoCellular Therapeutics Fundamentals Vs Peers
Comparing ImmunoCellular Therapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze ImmunoCellular Therapeutics' direct or indirect competition across all of the common fundamentals between ImmunoCellular Therapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as ImmunoCellular Therapeutics or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of ImmunoCellular Therapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing ImmunoCellular Therapeutics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare ImmunoCellular Therapeutics to competition |
| Fundamentals | ImmunoCellular Therapeutics | Peer Average |
| Return On Equity | -23.12 | -0.31 |
| Return On Asset | -4.4 | -0.14 |
| Current Valuation | (1.69 M) | 16.62 B |
| Shares Outstanding | 4.19 M | 571.82 M |
| Shares Owned By Insiders | 94.96 % | 10.09 % |
| Number Of Shares Shorted | 165.95 K | 4.71 M |
| Price To Earning | 0.02 X | 28.72 X |
ImmunoCellular Therapeutics Opportunities
ImmunoCellular Therapeutics Return and Market Media
The Stock did not receive any noticable media coverage during the period. Price Growth (%) |
| Timeline |
About ImmunoCellular Therapeutics Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including ImmunoCellular or other pink sheets. Alpha measures the amount that position in ImmunoCellular Therapeutics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards ImmunoCellular Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, ImmunoCellular Therapeutics' short interest history, or implied volatility extrapolated from ImmunoCellular Therapeutics options trading.
Build Portfolio with ImmunoCellular Therapeutics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Consideration for investing in ImmunoCellular Pink Sheet
If you are still planning to invest in ImmunoCellular Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ImmunoCellular Therapeutics' history and understand the potential risks before investing.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |